Effects of Exercise and Nutritional Interventions During Platinum Chemotherapy on Neuropathy: Examining the Interoceptive Brain System and Inflammation
ClinicalTrials.gov Identifier |
NCT05452902 |
Institution Name |
University of Maryland, Baltimore |
Full Institution Address |
655 W Lombard St, Baltimore, MD 21201 Baltimor Maryland 21201 United States |
Institution Phone |
(410) 706-7391 |
Institution Website |
http://www.iankleckner.com/ |
Additional Institutions |
|
Principal Investigator |
Dr. Ian Kleckner |
Principal Investigator Phone |
(410) 706-5981 |
Principal Investigator Email |
ian.kleckner@umaryland.edu |
Study Coordinator |
Javier Rosales |
Study Coordinator Phone |
(410) 706-7391 |
Study Coordinator Email |
jrosales@umaryland.edu |
Additional Study Coordinators |
Amelia Wagenknecht (202)503 4411 awagenknecht@umaryland.edu |
Study Overview |
Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and severe side-effect of platinum-based chemotherapy, often used to treat gastrointestinal cancers. There are very limited treatments for CIPN. This is a phase II randomized controlled trial to test the preliminary efficacy of exercise vs. nutrition education on CIPN. |
Enrollment Information |
4 |
Study Start Date |
20221025 |
Study End Date |
20251201 |
Study Purpose |
|
Inclusion Criteria |
|
Exclusion Criteria |
|
Required Tests Prior to Study |
|
Potential Side Effects |
|
Financial Assistance Available |
Yes |